Applied Biosciences Corp Valuation
| APPBDelisted Stock | USD 0.0009 0.00 0.00% |
Applied Biosciences seems to be fairly valued based on Macroaxis valuation methodology. Our model approximates the value of Applied Biosciences Corp from analyzing the firm fundamentals such as Operating Margin of (3.12) %, shares outstanding of 14.1 M, and Return On Equity of -2.22 as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Applied Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Applied Biosciences Corp is based on 3 months time horizon. Increasing Applied Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Applied Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Applied Stock. However, Applied Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 9.0E-4 | Real 8.77E-4 | Hype 0.001125 | Naive 8.81E-4 |
The real value of Applied Stock, also known as its intrinsic value, is the underlying worth of Applied Biosciences Corp Company, which is reflected in its stock price. It is based on Applied Biosciences' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Applied Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Applied Biosciences Corp helps investors to forecast how Applied stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Applied Biosciences more accurately as focusing exclusively on Applied Biosciences' fundamentals will not take into account other important factors: Applied Biosciences Total Value Analysis
Applied Biosciences Corp is presently projected to have valuation of 70.5 K with market capitalization of 70.5 K, debt of 0, and cash on hands of 21.27 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Applied Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
70.5 K | 70.5 K | 0 | 21.27 K |
Applied Biosciences Investor Information
About 32.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.31. Some equities with similar Price to Book (P/B) outperform the market in the long run. Applied Biosciences Corp recorded a loss per share of 0.2. The entity last dividend was issued on the 24th of October 2016. The firm had 1:10 split on the 24th of October 2016. Based on the key indicators related to Applied Biosciences' liquidity, profitability, solvency, and operating efficiency, Applied Biosciences Corp is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Applied Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Applied Biosciences has an asset utilization ratio of 19.36 percent. This suggests that the Company is making $0.19 for each dollar of assets. An increasing asset utilization means that Applied Biosciences Corp is more efficient with each dollar of assets it utilizes for everyday operations.Applied Biosciences Ownership Allocation
Applied Biosciences Corp retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.Applied Biosciences Profitability Analysis
The company reported the previous year's revenue of 707.06 K. Net Loss for the year was (2.63 M) with profit before overhead, payroll, taxes, and interest of 185.29 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Applied Biosciences' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Applied Biosciences and how it compares across the competition.
About Applied Biosciences Valuation
The delisted stock valuation mechanism determines Applied Biosciences' current worth on a weekly basis. Our valuation model uses a comparative analysis of Applied Biosciences. We calculate exposure to Applied Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Applied Biosciences's related companies.Applied Biosciences Corp. focuses on the development and commercialization of synthetic cannabinoid therapeuticsbiopharmaceuticals that target the endocannabinoid system to treat a range of diseases across various therapeutic areas. The company was incorporated in 2014 and is based in Beverly Hills, California. APPLIED BIOSCIENCES operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 25 people.
Applied Biosciences Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 13.4 M | |
| Retained Earnings | -5.5 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Applied Stock
If you are still planning to invest in Applied Biosciences Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Applied Biosciences' history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |